INTRODUCTION
============

Splenectomy is the preferred treatment for many hematologic diseases and is a necessary skill for any surgeon. In the early 1990s laparoscopic splenectomy (LS) took shape as a viable alternative to open surgery (OS) and quickly became the standard of care for many splenic disorders.^[@B1]^

Previously published data have shown that LS is associated with decreased postoperative pain; shorter recovery time; decreased blood loss; and decreased pulmonary, wound, and infectious complications.^[@B2],[@B3]^ A report published in 2009, based on cases recorded in the Nationwide Inpatient Sample (NIS) database, demonstrated that from 1998 through 2006 only 8.8% of splenectomies were performed with a laparoscopic approach, with no single year having greater than 12% of splenectomies performed laparoscopically.^[@B4]^ We used more recent data to update these statistics and identify any trends in the use of LS in the United States.

METHODS
=======

The NIS was queried for both OSs and LSs performed from the beginning of 2005 through 2010.^[@B5]^ The ICD-9 diagnostic and procedure codes that were included covered all splenic diseases, abdominal pain diagnoses (789.00, 789.02, 789.07, and 789.09), and procedure codes (41.5 for splenectomy). Laparoscopic peritoneoscopy (54.21) and laparoscopic enterolysis (54.51) were used to capture the laparoscopic cases. We excluded partial splenectomies and those performed for traumatic injury and vascular anomaly and as part of a pancreatectomy. The remaining patients were examined for age, comorbid conditions, and conversion to open splenectomy (CS). We then evaluated for postoperative complications, including deep vein thrombosis, pulmonary embolus, hemorrhage, portal vein thrombosis, postoperative pneumonia, cardiac complications, stroke, shock, renal failure, wound dehiscence, fistula, mortality, and length of stay. Cases were weighted to arrive at the total number of projected cases.

The top 8 admitting diagnoses leading to splenectomy were identified (**[Table 1](#T1){ref-type="table"}**). A bivariate logistic regression was then performed to evaluate for factors that predicted morbidity, mortality, and conversion to an open procedure. Statistical analysis was performed with SPSS (IBM Corporation, Armonk, NY, USA). Statistical significance was calculated with the *t* test or χ^2^, as appropriate, with significance set at *P* \< .05.

###### 

Indications for Splenectomy

  Indication                                          Laparoscopic   Open      Converted                   
  --------------------------------------------------- -------------- --------- ----------- --------- ----- ---------
  Idiopathic thrombocytopenic purpura                 2144           (43.43)   7909        (26.27)   501   (25.56)
  Hereditary spherocytosis                            487            (9.86)    2048        (6.80)    127   (6.48)
  Autoimmune hemolytic anemia                         439            (8.89)    1810        (6.01)    166   (8.47)
  Splenomegaly                                        258            (5.23)    2268        (7.53)    182   (9.29)
  Splenic lymphoma                                    222            (4.50)    1889        (6.27)    107   (5.46)
  Hypersplenism                                       177            (3.59)    1495        (4.97)    108   (5.51)
  Nonsplenic lymphoma                                 109            (2.21)    796         (2.64)    88    (4.49)
  Other diagnoses^[a](#TF1-1){ref-type="table-fn"}^   538            (10.90)   7192        (23.89)   386   (19.69)

Other diagnoses include: essential thrombocythemia, myelodysplastic syndrome, abdominal pain, Sezary\'s syndrome, Evans\' syndrome, thrombocytopenias and reticulosarcomas of the spleen.

RESULTS
=======

We identified 37,006 splenectomies performed during the 6-year study period. Fifty-three percent of the patients were women. Of the total cases, 30,108 (81.4%) patients had an open splenectomy (OS) and 4938 (13.3%) had a successful LS. Laparoscopic surgery was converted to open in 1960 (5.3%) patients. The most common indication for splenectomy was idiopathic thrombocytopenic purpura (ITP) with 10,554 (28.5%) cases (LS, 2144; OS, 7,909; CS, 501).

In 2007, the highest number of splenectomies was performed (n = 7050) with 1428 (20%) attempted laparoscopically and 420 (29.4%) converted to open. Each year had a conversion rate of at least 22.5% (**[Table 2](#T2){ref-type="table"}**). The average conversion rate for the study period was 28.4%.

###### 

Annual Breakdown of Splenectomies From 2005 Through 2010

  Year    Open            Completed Lap   Converted to Open   Total    Conversion Rate (%)
  ------- --------------- --------------- ------------------- -------- ---------------------
  2005    4,069 (85.6)    504 (10.6)      206 (4.3)           4,779    29.0
  2006    5,501 (82.5)    930 (13.9)      270 (4)             6,701    22.5
  2007    5,622 (80.2)    1,008 (14.4)    420 (6)             7,050    29.4
  2008    4,971 (79.4)    1,015 (16.2)    318 (5.1)           6,304    23.9
  2009    5,105 (83.2)    716 (11.7)      353 (5.8)           6,174    33.0
  2010    4,840 (81.4)    765 (12.9)      393 (6.6)           5,998    33.9
  Total   30,108 (81.4)   4,938 (13.3)    1,960 (5.3)         37,006   28.4

The baseline characteristics of the patients were analyzed, and significant differences were found in 13 of the 14 queried factors (**[Table 3](#T3){ref-type="table"}**). The CS group had significantly higher rates of hypertension (34.95%), diabetes mellitus (18.62%), hyperlipidemia (6.68%), obesity (8.83%), sleep apnea (3.83%), and mild (5.26%) or severe (7.3%) liver disease than those in the other 2 groups. The OS group had significantly higher rates of coronary artery disease (7.81%), congestive heart failure (4.78%), smoking (10.74%), COPD (7.45%), and chronic kidney disease (3.66%). The LS group had the highest rate of myocardial infarction (2.27%). The only comorbidity without significant difference between the groups was peripheral vascular disease.

###### 

Univariate Analysis of Baseline Characteristics

  Factor                                      Laparoscopic                              Open        Converted                                  Significance                   
  ------------------------------------------- ----------------------------------------- ----------- ------------------------------------------ -------------- ------- ------- ---------------------------------------------------------------------------------------------------
  Total                                       4,938^[a](#TF3-1){ref-type="table-fn"}^   13.34       30,108^[a](#TF3-1){ref-type="table-fn"}^   81.36          1,960   5.30    
  Age (years)                                 48.8 ± 22                                 51.3 ± 21   51.7 ± 20                                                                 
  Sex                                                                                                                                                                         
      Male                                    2,221                                     45.46       13,859                                     46.31          988     50.41   
      Female                                  2,665                                     54.54       16,067                                     53.69          972     49.59   
  Comorbidities                                                                                                                                                               
      Hypertension                            1,602                                     32.44       9,027                                      29.98          685     34.95   [\*](#TF3-2){ref-type="table-fn"}[†](#TF3-3){ref-type="table-fn"}[‡](#TF3-4){ref-type="table-fn"}
      Diabetes mellitus                       709                                       14.36       4,583                                      15.22          365     18.62   [†](#TF3-3){ref-type="table-fn"}[‡](#TF3-4){ref-type="table-fn"}
      Heart disease                                                                                                                                                           
          Coronary artery                     309                                       6.26        2,350                                      7.81           138     7.04    [\*](#TF3-2){ref-type="table-fn"}
          Myocardial infarction               112                                       2.27        642                                        2.13           26      1.33    [†](#TF3-3){ref-type="table-fn"}[‡](#TF3-4){ref-type="table-fn"}
          Congestive heart failure            140                                       2.84        1,439                                      4.78           87      4.44    [\*](#TF3-2){ref-type="table-fn"}
      Hyperlipidemia                          326                                       6.60        1,440                                      4.78           131     6.68    [\*](#TF3-2){ref-type="table-fn"}[†](#TF3-3){ref-type="table-fn"}
      Peripheral vascular disease             59                                        1.19        365                                        1.21           15      0.77    NS
      Obesity (BMI ≥ 30 kg/m^2^)              341                                       6.91        2,048                                      6.80           173     8.83    [†](#TF3-3){ref-type="table-fn"}[‡](#TF3-4){ref-type="table-fn"}
      Sleep apnea                             94                                        1.90        507                                        1.68           75      3.83    [†](#TF3-3){ref-type="table-fn"}[‡](#TF3-4){ref-type="table-fn"}
      Chronic obstructive pulmonary disease   268                                       5.43        2,244                                      7.45           96      4.90    [\*](#TF3-2){ref-type="table-fn"}[†](#TF3-3){ref-type="table-fn"}
      Chronic kidney disease                  154                                       3.12        1,103                                      3.66           49      2.50    [†](#TF3-3){ref-type="table-fn"}
      Liver disease                                                                                                                                                           
          Mild                                83                                        1.68        1,126                                      3.74           103     5.26    [\*](#TF3-2){ref-type="table-fn"}[†](#TF3-3){ref-type="table-fn"}[‡](#TF3-4){ref-type="table-fn"}
          Severe                              118                                       2.39        1,529                                      5.08           143     7.30    [\*](#TF3-2){ref-type="table-fn"}[†](#TF3-3){ref-type="table-fn"}[‡](#TF3-4){ref-type="table-fn"}
  Other risk factors                                                                                                                                                          
      Smoking                                 358                                       7.25        3,233                                      10.74          198     10.10   [\*](#TF3-2){ref-type="table-fn"}[‡](#TF3-4){ref-type="table-fn"}

Sex was not recorded in the database for some of the patients.

Laparoscopic vs open group.

Open vs converted group.

Laparoscopic vs converted group.

The LS group had a lower rate of morbidity (7.37%) when compared to that in the OS (10.39%) and CS (14.59%) groups. When compared to OS, LS resulted in a significantly lower postoperative incidence of deep vein thrombosis (0.6% vs 0.93%), hemorrhage (2.49% vs 3.31%), portal vein thrombosis (0.12% vs 0.55%), pneumonia (1.34% vs 2.45%), shock (0% vs 0.49%), infection (0.91% vs 1.43%), fistula (0% vs 0.11%), overall morbidity (7.37% vs 10.39%), and mortality (1.32% vs 2.53%).

When compared to CS, successful LS results showed fewer postoperative incidences of deep vein thrombosis (0.6% vs 1.28%), hemorrhage (2.49% vs 9.29%), shock (0% vs 0.51%), and overall morbidity (7.37% vs 14.59%). There was no significant difference in the mortality rate between patients who underwent LS and those who had CS (1.32% vs 1.28%; NS).

Patients who underwent OS experienced less postoperative hemorrhage (3.31% vs 9.29%; *P* \< .05) and decreased overall morbidity (10.39% vs 14.50%; *P* \< .05) when compared to those who whose laparoscopic procedure was converted to open. Patients who underwent CS had lower rates of postoperative portal vein thrombosis (0.20% vs 0.55%), pneumonia (1.43% vs 2.45%), and mortality (1.28 vs 2.53%) when compared to those who underwent OS. Length of stay was significantly less in the LS group when compared to that in both the OS and CS groups.

Factors that led to conversion to open surgery were analyzed with bivariate logistical regression. The results revealed that autoimmune hemolytic anemia (odds ratio \[OR\] 1.36; *P* = .002), nonsplenic lymphoma (OR 1.83; *P* \< .001), splenomegaly (OR 1.30; *P* = .007), and hemorrhage (OR 3.23; *P* \< .001) increased the risk for conversion to OS (**[Table 4](#T4){ref-type="table"}**).

###### 

Bivariate Logistical Regression Analysis of Factors That Led to Conversion to Open Surgery

  Factor                                *P*    OR     95% CI   
  ------------------------------------- ------ ------ -------- -------
  Hereditary spherocytosis              .546   0.94   0.756    1.16
  Autoimmune hemolytic anemia           .002   1.36   1.117    1.657
  Hypersplenism                         .183   1.17   0.929    1.467
  Nonsplenic lymphoma                   .000   1.83   1.426    2.348
  Splenomegaly                          .007   1.30   1.075    1.577
  Splenic lymphoma                      .437   0.91   0.728    1.147
  Idiopathic thrombocytopenic purpura   .195   0.91   0.782    1.052
  Hemorrhage                            .000   3.23   2.736    3.803
  Other diagnoses                       .223   0.91   0.776    1.061

Comorbid conditions significantly associated with an increased risk of death were chronic obstructive pulmonary disease (OR 2.22; *P* \< .005), peripheral vascular disease (OR 2.15; *P* \< .005), chronic kidney disease (OR 2.58; *P* \< .005), congestive heart failure (OR 4.44; *P* \< .005), and severe liver disease (OR 5.59, *P* \< .005). Smoking, obesity, hypertension, and mild liver disease were not associated with increased postoperative mortality (**[Table 5](#T5){ref-type="table"}**).

###### 

Bivariate Logistical Regression Analysis of Comorbid Conditions That Increased the Risk of Mortality

  Comorbidity                             *P*      OR      95% CI   
  --------------------------------------- -------- ------- -------- -------
  Diabetes mellitus                       .143     0.858   0.700    1.053
  Hypertension                            .005     0.783   0.659    0.929
  Chronic obstructive pulmonary disease   \<.005   2.216   1.812    2.711
  Peripheral vascular disease             \<.005   2.146   1.423    3.236
  Chronic kidney disease                  \<.005   2.579   2.036    3.265
  Congestive heart failure                \<.005   4.435   3.663    5.370
  Severe liver disease                    \<.005   5.590   4.089    7.642

Postoperative complications that portended an increased risk of death were identified by using bivariate logistical regression. Pulmonary embolus (OR 1.91; *P* = 0.033), infection (OR 2.53; *P* \< .005), hemorrhage (OR 3.25; *P* \< .005), wound dehiscence (OR 4.85; *P* \< .005), cardiac complications (OR 4.98; *P* \< .005), and shock (OR 11.38; *P* \< .005) were found to significantly increase the risk of death after splenectomy (**[Table 6](#T6){ref-type="table"}**). The surgical approach did not predict mortality.

###### 

Bivariate Logistical Regression Analysis of Postoperative Complications That Increased the Risk of Mortality

  Complication             *P*      OR      95% CI   
  ------------------------ -------- ------- -------- -------
  Pulmonary embolus        .033     1.91    1.054    3.458
  Pneumonia                .738     0.92    0.582    1.467
  Infection                \<.005   2.52    1.678    3.797
  Fistula                  .998     0.00    0.000    ---
  Deep vein thrombosis     .691     0.87    0.446    1.708
  Portal vein thrombosis   .145     1.70    0.833    3.446
  Hemorrhage               \<.005   3.25    2.301    4.589
  Stroke                   .998     0.00    0.000    ---
  Wound dehiscence         \<.005   4.85    2.515    9.361
  Cardiac complication     \<.005   4.98    3.458    7.177
  Shock                    \<.005   11.38   7.636    16.95
  Renal failure            .169     0.52    0.202    1.323

Postoperative morbidity associated with the method of splenectomy was analyzed by bivariate logistical regression, and CS (OR 2.45; 95% CI 2.058--2.906; *P* \< .005) and OS (OR 1.61; 95% CI 1.422--1.817; *P* \< .005) were found to increase the risk when compared to LS.

DISCUSSION
==========

Although there has been a modest increase in the percentage of LSs, the overall rate remains low, relative to other advanced laparoscopic procedures (**[Table 7](#T7){ref-type="table"}**).^[@B1],[@B4],[@B6][@B7][@B22]^ The average rate of successful LSs during the study period was 13.4% (range, 10.6%--16.2%). There was a small but significant increase in the rate of completed LSs over the study period. The rate is significantly higher when compared to NIS data from 1998 to 2006 (8.8% vs 13.4%, *P* \< .05).^[@B4]^

###### 

Published Rates of Conversion Among Basic and Complex Laparoscopic Procedures

  Laparoscopic Procedure     Year of Publication   First Author    Conversion Rate (%)   Patient Base
  -------------------------- --------------------- --------------- --------------------- --------------------
  Cholecystectomy            2004                  Livingston^6^   5.0--10.0             National
  2010                       Sakpal^7^             4.9             Single institution    
  2010                       Kaafarani^8^          9.0             VA system             
  Colectomy                  2005                  Tekkis^9^       10.0                  Single institution
  2012                       Simorov^10^           15.8            National              
  2013                       Prakash^11^           2.2--3.7        Single institution    
  Appendectomy               2008                  Schick^12^      6.2                   Single institution
  2012                       Sakpal^13^            4.2             Single institution    
  2013                       Abe^14^               10              Single institution    
  Sleeve gastrectomy         2008                  Lalor^15^       1.2                   Single institution
  2011                       Boza^16^              0.7             Single institution    
  2012                       Boza^17^              0.1             Single institution    
  2013                       Trastulli^18^         0.0             Review                
  Roux-en-Y gastric bypass   2003                  Podnos^19^      2.2                   Review
  2012                       Boza^17^              0.7             Single institution    
  2013                       Trastulli^18^         0.0             Review                
  Adrenalectomy              2004                  Gonzalez^20^    1.0                   Single institution
  2011                       Nguyen^21^            0.2             Single institution    
  2013                       Tiberio^22^           6.1             Single institution    

We also found a high rate of conversion from laparoscopic to open surgery. The average rate in our study period was 28.4% (range, 22.5%--33.9%). The rate is considerably higher when compared to other basic and advanced laparoscopic operations. For example, laparoscopic colectomies and laparoscopic bariatric procedures have, at most, a reported conversion rate of 15.8% and 2.2%, respectively (**[Table 7](#T7){ref-type="table"}**). Our data suggest that bleeding and splenomegaly are intraoperative events that can lead to increased conversion, with ORs of 3.23 and 1.3, respectively (**[Table 6](#T6){ref-type="table"}**). In addition, the overall low number of splenectomies being performed may limit the development of the skill and familiarity needed for LS to be performed more often.

As reported in previous studies, we demonstrated several benefits of LS over OS. The data analysis shows that LS was associated with fewer postoperative complications, lower mortality, and a shorter length of stay when compared with the outcomes of OS and CS. Morbidity was highest in the CS group (14.6%) and was associated with a higher rate of hemorrhage (9.3%). Mortality was significantly lower in the LS group when compared to that in the OS group (1.32% vs 2.52%; *P* \< .001).

Despite the potential for significantly reduced morbidity, mortality, and length of stay, most splenectomies continue to be open. A specific reason for this cannot be determined from the database, but it may be related to the surgeon\'s skill and comfort in performing the procedure, the relative scarcity of splenectomies overall, and the challenging anatomy and pathophysiology that can coexist in a patient. Thrombocytopenia and splenomegaly are frequently encountered when performing splenectomy and, although challenging, the LS approach has been shown to be safe and associated with decreased length of stay, transfusion requirements, and mortality compared to those factors with OS.^[@B3]^ We must emphasize that patient safety is paramount, and if the surgeon elects to use an open procedure or converts to open, it should not be viewed as a failure.

To increase the number of cases being completed laparoscopically and decrease the conversion rate, we suggest that fellowship-trained, advanced laparoscopic surgeons perform LS in most instances. It has been shown that the addition to a general surgery practice of a physician who is fellowship-trained in minimally invasive surgery increases the proportion of procedures that are completed laparoscopically.^[@B23],[@B24]^ The advanced surgical training acquired during fellowship promotes meticulous dissection techniques, as well as a greater comfort level with the minimally invasive approach for more complex procedures and confidence in managing intraoperative complications without converting to open surgery. As the number of fellowship-trained, advanced laparoscopic surgeons increases, we anticipate that more LSs will be successfully completed. However, the technical challenges associated with LS cannot be underestimated. Even in the most experienced hands, conversion to an open procedure will occur occasionally. This decision obviously requires consideration of the given disease process, individual patient factors, and intraoperative findings.

This study has limitations related to the deficiencies inherent in administrative databases. The NIS database used in this study (it was redesigned in 2012) is a record of data compiled from discharge and procedural diagnoses across 1000 hospitals of all types and sizes and in all types of locations. It is designed to capture data on a sample of 20% of the patients across the United States. The data are weighted to arrive at the total number of cases per year.^[@B5]^ This method is open to the over- and underreporting of data. It is dependent on the coders of the institution who base their codes on chart documentation. There is also a lack of standardization among some complications, which contain unquantifiable data such as hemorrhage. Although the NIS is a robust database, it is retrospective and nonrandomized, thus allowing the data to be marred with selection and input biases.

CONCLUSIONS
===========

In recent years, the rate of LS has increased significantly. Although LS is regarded as the most desired approach, it remains underused for reasons that remain unclear. Successfully completed laparoscopies are associated with less morbidity and mortality. The rate of conversion to an open procedure in splenectomies is the highest among advanced laparoscopic procedures; splenomegaly and hemorrhage predict a conversion.
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